Tuesday, November 8, 2016

Wednesday, November 9, 2016

SESSION 1: Different Directions for Inhaled and Nasal Drug Delivery

SESSION 2: Workshops

  • 2:00 p.m. - 6:00 p.m.

    Sponsor: Aptar Pharma
    Moderator: Gerallt Williams, Ph.D.

    The following companies each sponsored 60-minute interactive presentations on new technologies and services related to nasal and pulmonary drug delivery. Meeting participants selected and attended THREE of these sessions, on their Registration Form.

    Amcor
    Blister Based Dry Powder Inhalers: How to Get it Right First Time

    H&T Presspart
    pMDI Characterization and Development of Generic Equivalent Systems

    Harro Höfliger
    A New Dosing System to Fill Dry Powder Inhaler Discs with Integrated 100% In-line Mass Verification 

    InnovaSystems 
    Modern Principles of Developing Actuation Methods for Characterization of Nasal Sprays / Metered Dose Inhalers

    Intertek
    Product Characterization Studies  - What are they? Why Are They Done and What is Involved?

    Malvern Instruments / Next Breath
    Bioequivalence Study Strategies Using Laser Diffraction for Nebulized Inhalation Solutions and Suspensions

    Proveris Scientific
    Demonstrating Orally Inhaled and Nasal Drug Product Understanding through Quality by Design

Thursday, November 10, 2016

SESSION 3: Fighting COPD, TB and Respiratory Infections with Inhalation Therapy

SESSION 4: Advancing Regulatory Science of Inhaled Products

Friday, November 11, 2016

SESSION 5: Optimizing DPI Formulation and Device Partnerships

SESSION 6: Quality by Design – Understanding the Science of Aerosol Clouds

↑ Back to Top